Physician profile
David Altamira
NPI 1881693307
$1,534.07
in general payments reported to CMS, 2019-2025
16 companies · $72.88 in 2025
The $72.88 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $99.40 · 2021: $320 · 2022: $331 · 2023: $47.81 · 2024: $459 · 2025: $72.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.91 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $370.92 | 2020-2022 | |
| Galderma Laboratories, L.P. | $211.73 | 2019-2024 | |
| Merz North America, INC. | $159.14 | 2020-2021 | |
| Smith+Nephew, INC. | $149.80 | 2024 | Versajet |
| Mentor Worldwide LLC | $110.86 | 2019-2024 | Mentor Cpx 2 Breast Tissue Expander |
| Revance Therapeutics, INC. | $104.90 | 2024 | Daxxify |
| Tela Bio, INC. | $87.41 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Tepha INC | $72.46 | 2019 | |
| Bard Peripheral Vascular, INC. | $71.12 | 2021 | |
| Wound Management Technologies, INC | $49.53 | 2019 | |
| Avita Medical Americas, LLC | $47.41 | 2025 | Recell, Permeaderm, Cohealyx |
| Depuy Synthes Sales INC. | $23.30 | 2024 | Matrixneuro |
| Allergan, INC. | $23.09 | 2019 | |
| Acell, INC. | $17.70 | 2020 | |
| Aroa Biosurgery Incorporated | $17.39 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $17.31 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Altamira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.